New Study Shows DigeSEB Super™ Enhances Digestion
CHINO, Calif., May 24, 2024 /PRNewswire/ — A recent study found Specialty Enzymes & Probiotics’ powerful digestive enzyme blend, DigeSEB Super™, assists endogenous digestive enzymes in breaking down food, resulting in reduced food viscosity and improved digestion. The study aimed t
Mycotoxin Testing Market worth $2.3 billion by 2029 – Exclusive Report by MarketsandMarkets™
CHICAGO, May 24, 2024 /PRNewswire/ — The Mycotoxin Testing Market is estimated at USD 1.6 billion in 2024 and is projected to reach USD 2.3 billion by 2029, at a CAGR of 6.7% from 2024 to 2029 according to a report published by MarketsandMarkets™. The expansion of the agricultural sector, co
Epsilor is Proud to Announce that it has been chosen by RAFAEL to Develop and Produce the Multi-Charger Rack (MCR) for the SPIKE SR and SPIKE LR Launchers’ Batteries
With 5 drawers, each able to charge up to 8 batteries, the Multi-Charger Rack (MCR) enables simultaneous charging of up to 40 batteries, in a maximum charging time of 6 hours for the SPIKE LR battery and 3 hours for the SPIKE SR battery. BEIT SHEMESH, Israel, May 24, 2024 /PRNewswire/ — Epsilo
XData Group Introduces Enhanced Website and Refreshed Brand Image
TALLINN, Estonia, May 24, 2024 /PRNewswire/ — XData Group, a leading B2B software development company specializing in innovative solutions for the European banking sector, is proud to announce the launch of its revamped website. The company’s new look is designed to reflect its innovati
URBAN SPORTS AND STREET ARTS MEET IN SINGAPORE AS PART OF A GLOBAL WARM-UP TO THE PARIS 2024 OLYMPIC GAMES
The unique event, which is among the first global events created to build excitement for the upcoming Olympic Games, sees French and Singaporeans athletes and artists coming together to revitalise the iconic skate park in Singapore SINGAPORE, May 24, 2024 /PRNewswire/ — In the lead up to the
Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting
The ELECTRA and ELEVATE studies were designed to overcome different resistance mechanisms and improve patient outcomes with oral-oral combination options.Updated results from the ELECTRA study, evaluating elacestrant in combination with abemaciclib regardless of metastatic site, show a safety profi
STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024
STC-15 is the first METTL3 inhibitor to enter clinical development Clinical data will include safety, pharmacology, target modulation, and clinical activity CAMBRIDGE, England, May 24, 2024 /PRNewswire/ — STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogram
Compassionate closure for those who are unable to fulfil hopes and expectations of fertility treatment
MANILA, Philippines, May 24, 2024 /PRNewswire/ — Compassionate closure is a vital aspect of the holistic care of millions of people each year who are left with lost hopes and dreams of parenthood after assisted conception. In the dynamic and rapidly expanding field of assisted reproductive tec
Inspur Cooperates with Partners to Promote the Development of Data Center Industry in Southeast Asia
JINAN, China, May 24, 2024 /PRNewswire/ — Recently, Inspur signed strategic cooperation agreements with Malaysia’s large data center operator and Singapore’s A3 Capital to jointly promote the development of the data center industry in Southeast Asia. The Malaysian partner is a wel
Newrizon Partnered With Al Yemni Group, Bringing Its Futuristic EV Truck In GCC Region
RIYADH, Saudi Arabia , May 24, 2024 /PRNewswire/ — Recently in Riyadh, Newrizon, a startup dedicated in electrifying and revolutionizing urban delivery vehicles, signed dealership agreement and intent purchase order with Al Yemni Group, authorizing it as Newrizon’s exclusive dealer in t
